Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma
Materials Today Bio · 2024-10 · 28 · 101199
DOI: 10.1016/j.mtbio.2024.101199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2024-10. Verfasst von Naga Malleswara Rao Nakka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Sciences, Jacksonville, FL, 32224, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease where standard-of-care chemotherapeutic drugs have limited efficacy due to the development of drug resistance and poor drug delivery caused by a highly desmoplastic tumor microenvironment. Combining multiple drugs in a tumor-targeting carrier would be a favorable approach to overcome these limitations. Hence, a tumor-targeted peptide (TTP) conjugated amphiphilic tri-block copolymer was developed to make targeted polymer nanoparticles (TTP-PNPs) serving as a vehicle for carrying gemcitabine (Gem), paclitaxel (PTX), and their combination (Gem + PTX). The TTP-PNPs in the form of empty polymer (P), single drug-loaded [P(Gem) and P(PTX)], and dual drug-loaded [P(Gem + PTX)] polymer nanoformulations exhibited stable and homogenous spherical shapes with 110-160 nm size. These nanoformulations demonstrated excellent stability under in vitro physiological conditions and led to an efficient release of the drugs in the presence of reduced glutathione (GSH). The efficacy of these nanoparticles was thoroughly evaluated in vitro and in vivo, demonstrating a notable capacity to selectively target and restrict PDAC cells (PANC-1 and KPC) growth. The cellular uptake and biodistribution study showed a significantly higher tumor-targeting ability of TTP-PNPs than PNPs without TTP. Notably, P(Gem + PTX) exhibited the lowest IC50 compared to all other controls and showed heightened synergistic effects in both cell lines. Furthermore, P(Gem + PTX) showed a significantly better tumor reduction and median overall survival in mouse models than single drug-loaded TTP-PNPs or a combination of free drugs (Gem + PTX). In summary, our TTP-PNP system shows great promise as a novel platform for delivering Gem + PTX specifically to pancreatic cancer (PC), maximizing the therapeutic benefits with lower concentrations of the drugs and potentially reducing toxic side effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Sciences, Jacksonville, FL, 32224, USA.
- Polymers and Functional Materials and Fluoro-Agrochemicals Department, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad, 500007, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Sciences, Jacksonville, FL, 32224, USA.
- Department of Medicine, Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Nakka, N. M. R., Rachamala, H. K., Angom, R. S., Indla, N. R., Dutta, S. K., Wang, E., Bhattacharya, S., Sesha Sainath, A. V., Babiker, H., Pal, K., & Mukhopadhyay, D. (2024). Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma. Materials Today Bio, 28, 101199. https://doi.org/10.1016/j.mtbio.2024.101199
Vancouver
Nakka NMR, Rachamala HK, Angom RS, Indla NR, Dutta SK, Wang E, et al. Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma. Materials Today Bio. 2024;28:101199. doi:10.1016/j.mtbio.2024.101199
BibTeX
@article{Nakka2024,
author = {Nakka, Naga Malleswara Rao and Rachamala, Hari Krishnareddy and Angom, Ramcharan Singh and Indla, Nagamalleswara Rao and Dutta, Shamit Kumar and Wang, Enfeng and Bhattacharya, Santanu and Sesha Sainath, Annadanam V and Babiker, Hani and Pal, Krishnendu and Mukhopadhyay, Debabrata},
title = {Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma},
journal = {Materials Today Bio},
year = {2024},
volume = {28},
pages = {101199},
doi = {10.1016/j.mtbio.2024.101199}
}
EUVIMED